This page is general health information. It is not advice about your own treatment and it does not promote any medicine. Whether a medicine is right for you is a decision for you and your prescriber.
What Rubifen is
Rubifen is a brand of methylphenidate, the stimulant medicine most often tried first for ADHD in New Zealand. Medsafe's data sheet describes Rubifen as part of a broader treatment programme, alongside psychological, educational and social support.
The three Rubifen products
| Rubifen | Rubifen SR | Rubifen LA | |
|---|---|---|---|
| Form | Immediate-release tablet | Sustained-release tablet | Long-acting capsule |
| Strengths | 5, 10, 20 mg | 20 mg | 10, 20, 30, 40, 60 mg |
| How often | 2 or 3 times a day | Once a day, usually morning | Once a day, usually morning |
| Starts working | 20 minutes to 1 hour | 1 to 2 hours | About 1 hour |
| How long it lasts | 3 to 5 hours | Up to 8 hours | 6 to 8 hours |
| With food? | With or without | With food | With or without, the same way each time |
From Healthify's methylphenidate page. Healthify noted in October 2026 that the 10, 20 and 30 mg Rubifen LA strengths were available first, with 40 and 60 mg expected later that month.
Rubifen vs Ritalin
The active ingredient is the same. The differences are the strengths and forms on offer:
- Immediate release. Rubifen comes in 5, 10 and 20 mg tablets. Ritalin comes in a 10 mg tablet. Both are in Pharmac's first-line funding group.
- Long acting. Rubifen LA is a generic version of Ritalin LA, supplied by AFT Pharmaceuticals. Pharmac funds Rubifen LA as a first-line option and Ritalin LA as a second-line option. Rubifen LA also adds a 60 mg strength.
- Sustained release. Rubifen SR (20 mg, up to 8 hours) has no current Ritalin equivalent in New Zealand.
bpac says generic methylphenidate products are considered bioequivalent, but some people notice a difference when they switch brands, so prescribers are advised to monitor more closely after a change. Pharmac's advice to pharmacists is that one funded immediate-release brand can be swapped for another without a new prescription, but a switch between long-acting products needs a new prescription.
Why Rubifen LA was funded
Pharmac says methylphenidate supply problems have affected every form in New Zealand since September 2023 and are expected to continue through 2026. Adding Rubifen LA was meant to increase overall supply and reduce the risk of shortages. Pharmac says there are now eight funded brands of methylphenidate. Its start date moved from 1 July to 1 October 2026 because of manufacturing timelines.
How it is taken
From Healthify:
- Rubifen tablets: with or without food. If you have trouble sleeping, take the last dose at least 4 to 6 hours before bed.
- Rubifen SR: with food, swallowed whole. Do not crush or chew it.
- Rubifen LA: with or without food, the same way each time. The capsule can be opened and the beads sprinkled on a small amount of cold soft food, then swallowed straight away without chewing.
- Do not stop suddenly. Talk to your prescriber first.
Side effects
Healthify lists these common side effects of methylphenidate, which usually settle:
- stomach upset
- reduced appetite or weight loss
- headache, muscle or joint pain
- sweating and dry mouth
- runny or blocked nose, cough
- trouble sleeping.
Contact your prescriber straight away, or call Healthline free on 0800 611 116, about anxiety or mood changes, vision changes or eye pain, chest pain, seizures, a racing heart, or thoughts of suicide or self-harm, agitation, aggression or worsening low mood. More in ADHD medication side effects.
Prescription rules
Rubifen is a controlled drug. A prescription can cover up to three months, the pharmacy hands out 30 days at a time, the first supply must be collected within 7 days, and repeats come from the same pharmacy. The full rules are on the Ritalin page.